Grifols reagents - procleix ultrio elite, west nile virus, & babesia
Ended Purchase Order Awarded Last action
- Contract number
- HT941024P0206
- Awardee
-
Grifols Diagnostic Solutions Inc. UEI R4N2Y6E9D6H7
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $711,317
Award facts
- Opportunity
-
- Notice of Intent to Sole Source Grifols Reagent Annual Drop Shipment (Procleix - Ultrio Elite, West Nile Virus, & Babesia) for U. S. Naval Hospital Okinawa, Japan Pre-Solicitation · HT941024N0089 · Posted Jun 26, 2024
- Contract value 30% obligated
-
- $711,317.00 Current, with exercised options
- $2,407,078.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Emeryville, CA 94608, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $248,777 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $269,160 | |
| Supplemental Agreement for work within scope | $193,380 | |
| Original award | $0 |
About this award
The Defense Health Agency awarded a $2.4 million firm fixed-price purchase order to Grifols Diagnostic Solutions Inc., the original equipment manufacturer and sole source provider, for annual dropshipment of FDA-approved Procleix reagents to support the United States Naval Hospital Okinawa in Japan. The contract, which extends through July 2, 2029, covers three specific test assays for the Procleix Panther nucleic acid testing analyzer: the Ultrio Elite assay, West Nile Virus assay, and Babesia assay. These test kits are critical for detecting blood transfusion-transmitted infections in military blood bank operations. As a sole-source award made without set-aside designation, this contract reflects Grifols' established position as the exclusive authorized supplier of these specialized diagnostic reagents to the Department of Defense healthcare system.
This award represents a continuation of Grifols' significant market presence within federal military healthcare procurement. The contractor currently maintains seven active indefinite delivery vehicles across federal agencies with combined ceiling values exceeding $23 million, including substantial blanket purchase agreements with Air Education and Training Command and multiple Veterans Integrated Service Networks for similar Procleix diagnostic products and services. The Defense Health Agency's selection of Grifols for this sole-source requirement underscores the company's technical expertise and the specialized nature of original equipment manufacturer reagent supply, wherein only the OEM can provide guaranteed compatibility and regulatory compliance for the Procleix Panther analyzer systems deployed across military treatment facilities.
Quick answers
Who was awarded contract HT941024P0206?
HT941024P0206 was awarded to Grifols Diagnostic Solutions Inc. by Defense Health Agency (Department of Defense) on October 1, 2024.
How much is contract HT941024P0206 worth?
The government has obligated $711,317 on HT941024P0206. Its potential value, with all options, is $2,407,078.
Was contract HT941024P0206 competed?
The extent of competition for HT941024P0206 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award